Create issue ticket

327 Possible Causes for ICP 1, compound

Show results in: Italiano

  • Diffuse Large B-Cell Lymphoma

    Collectively, these findings suggest that CBBM could be a promising lead compound for treatment of c-Myc-driven DLBCL.[ncbi.nlm.nih.gov] Four risk groups were formed: group ICPS   0, ICPS   1, ICPS   2 and ICPS   3.[ncbi.nlm.nih.gov] New biopsies were taken that revealed a mild diffused dermo-hypodermic cellular infiltrate compounded by small-sized T lymphocytes, with predominance of CD8.[ncbi.nlm.nih.gov]

  • Metocurine

    COMPOUND: C07919 Entry C07919 Compound Name Metocurine Formula C40H48N2O6 Exact mass 652.3512 Mol weight 652.8189 Structure Pathway map07221 Nicotinic cholinergic receptor[genome.jp] Four minutes after thiopental administration (7 min after MTC), after a 1-min period of relatively stable arterial pressure and ICP, Sch 1 mg/kg was administered as a bolus[ncbi.nlm.nih.gov] Two of the compounds, metocurine and atracurium were highly cross-reactive with the currently used myoneural blockers; fazadinium was weakly cross-reactive and vecuronium[ncbi.nlm.nih.gov]

  • Leflunomide

    […] high-quality, ready-to-screen compounds.[sigmaaldrich.com] Pereira ICP 1 , Sousa NCF 1 , Pereira DMS 1 , Mendes SJF 1 , Muniz TF 1 , Colares VLP 1 , Silva BLR 1 , Monteiro CRAV 1, 2 , Martins MMRS 3 , Fernandes AMR 4 , Fernandes ES[ncbi.nlm.nih.gov] Isoxazoles / Heteroaromatic compounds / Secondary carboxylic acid amides / Oxacyclic compounds / Azacyclic compounds / Organopnictogen compounds / Organooxygen compounds[drugbank.ca]

  • Rheumatoid Arthritis

    Pereira ICP 1 , Sousa NCF 1 , Pereira DMS 1 , Mendes SJF 1 , Muniz TF 1 , Colares VLP 1 , Silva BLR 1 , Monteiro CRAV 1, 2 , Martins MMRS 3 , Fernandes AMR 4 , Fernandes ES[ncbi.nlm.nih.gov] Areas covered: In this review, the authors described the technological trends and the main players involved in the R&D process related to biological compounds employed in[ncbi.nlm.nih.gov] Other lumps were punctured and injected with compound betamethasone injection.[ncbi.nlm.nih.gov]

  • Conductive Hearing Loss

    It can also happen gradually over time when one hearing loss is compounded by another.[healthyhearing.com] DPOAEs were measured in guinea pigs before and after induction of a CHL (1 ear) and during increased ICP (1 ear), and in humans during changes of the postural position to[ncbi.nlm.nih.gov] […] alter the ICP (4 ears).[ncbi.nlm.nih.gov]

  • Meningoencephalitis

    Elevated ICP should be managed aggressively, maintaining an ICP 1 – 3 , 24 it should be administered concurrently with the antimicrobial agents.[pediatrics.aappublications.org] Efforts to reach an attorney for Brookwood and the compounding center have been unsuccessful.[blog.al.com] 2019 Billable/Specific Code Applicable To Cranial neuritis Meningoencephalitis Polyneuropathy mercury T56.1 ICD-10-CM Diagnosis Code T56.1 Toxic effects of mercury and its compounds[icd10data.com]

  • Paraneoplastic Neurologic Syndrome

    ) of 50-65 mm Hg Propofol is 1 st choice sedative, may protect from increased ICP Avoid vasopressin which worsens hyperammonemia and increases cerebral blood flow Avoid hypo[ucsfmed.wordpress.com] We report a case of a patient with occult small cell lung cancer that was initially compounded by clinical features of a paraneoplastic neurologic syndrome.[ncbi.nlm.nih.gov] […] routine use of lactulose (used anyway to reduce ammonia) Prophylactic antibiotics and hypertonic saline Hypothermia if refractory Maintain cerebral perfusion pressure (MAP – ICP[ucsfmed.wordpress.com]

  • Naegleria Fowleri

    Elevated ICP should be managed aggressively, maintaining an ICP 1 – 3 , 24 it should be administered concurrently with the antimicrobial agents.[pediatrics.aappublications.org] Mepacrine was the most effective compound with the minimum inhibitory concentration (MIC100) against A.polyphaga [corrected] The most effective drugs against N. fowleri expressed[ncbi.nlm.nih.gov] Finally, novel compounds for potential treatments are discussed as well as research on vaccine development against PAM. Copyright 2018 Elsevier Inc. All rights reserved.[ncbi.nlm.nih.gov]

  • Cholestasis

    In conclusion, inter-individual susceptibility exists towards drug-induced cholestasis, which depends on the compound as well as the exposure time.[ncbi.nlm.nih.gov] In the literature, the incidence of ICP ranges from 0.1 - 15.6%.[1] Women diagnosed with ICP most often present with itching, which may be severe.[clinicaltrials.gov] Furthermore, the tBMDL values for each test compound were in good agreement with the relevant no observed adverse effect level.[ncbi.nlm.nih.gov]

  • 2-Hydroxyglutaric Aciduria

    RESULTS: Next-generation sequencing (NGS) revealed two novel compound heterozygous frameshift mutations, c.407 del A (p.K136SfsTer3) and c.699_c700 ins A (p.D234RfsTer42),[ncbi.nlm.nih.gov] Author information 1 Laboratory of Physiological Chemistry, ICP and Université Catholique de Louvain, UCL 7539, Avenue Hippocrate 75, 1200 Brussels, Belgium.[ncbi.nlm.nih.gov] The other patient was compound heterozygous for a missense mutation (c.440T-- G; p.Ile147Ser) and a splice-site mutation (IVS1-23A-- G) that resulted in a null allele.[ncbi.nlm.nih.gov]

Further symptoms